Topic: National Cancer Research Network
Conditions
Interventions
Mindfulness based stress reduction (MBSR) was developed by Jon Kabat Zinn (University of Massachusetts Medical Center) and is a "specific structured psycho educational and skills based package" that e
Sponsors
Southampton University Hospitals NHS Trust (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. After diagnosis of metastatic breast cancer and stable enough to have a real likelihood of completing the study as assessed by the recruiting oncologists 2. Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 - 1, thus excluding bed bound and frail patients 3. Estimated life expectancy of at least 6 months to enable retention and minimise group disruption 4. Able to provide informed written consent 5. Fluent English; the questionnaires are written and validated in English 6. Assessed as eligible by the mindfulness instructor following the clinician's initial approval 7. Female subjects, no age range
Exclusion criteria
Exclusion criteria: 1. Substance misuse or other issues that may jeopardise the health of individuals participating in the intervention will be excluded 2. Comorbitities that makes it unlikely that participants will complete the study (including borderline personality disorder, major psychotic illness) 3. Participants who are felt to be too distressed to be approached will be excluded (this will be determined by the clinicians)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brief Fatigue Inventory, measured prior to intervention at baseline, during the intervention at months 1 and 2 and post-intervention at months 3 and 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. EORTC-QLQ-C30, measured prior to intervention at baseline and post-intervention at month 5 2. EuroQol EQ5D, measured prior to intervention at baseline, during the intervention at months 1 and 2 and post-intervention at months 3 and 5 3. Hospital Anxiety and Depression Scale, measured prior to intervention at baseline, during the intervention at months 1 and 2 and post-intervention at months 3 and 5 4. Toronto Mindfulness Scale, measured prior to intervention at baseline, during the intervention at months 1 and 2 and post-intervention at months 3 and 5 | — |
Countries
England, United Kingdom
Outcome results
None listed